The Kenneth Rainin Foundation's Innovator Awards fund bold, interdisciplinary research to advance scientific understanding and treatment of Inflammatory Bowel Disease (IBD).
Funder: Kenneth Rainin Foundation
Due Dates: September 30, 2026: Letter of Inquiry (LOI) deadline | February 5, 2027: Full proposal (by invitation) deadline
Funding Amounts: Up to $150,000 for individual projects; up to $300,000 for collaborative projects; 1-year term with possible 2-year renewal.
Summary: Supports innovative, collaborative research to advance the understanding, diagnosis, and treatment of Inflammatory Bowel Disease (IBD).
Key Information: LOIs must be submitted online; full proposals are by invitation only; open to global applicants from diverse scientific backgrounds.
The Kenneth Rainin Foundation's Innovator Awards provide funding for pioneering research projects that aim to improve the prevention, prediction, diagnosis, and treatment of Inflammatory Bowel Disease (IBD). The program encourages bold, high-risk ideas and fosters collaboration across disciplines, including basic, translational, and clinical science. Projects utilizing artificial intelligence, machine learning, big data analytics, and various model systems are especially encouraged. The focus is on supporting early-stage, innovative research that can lead to transformative discoveries and accelerate therapeutic development in IBD.